ArticleBritish journal of cancer2026

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.

Paulina Czajka-Francuz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.